DE69828513D1 - Verfahren zur herstellung von nanokapseln des vesikulären typs - Google Patents
Verfahren zur herstellung von nanokapseln des vesikulären typsInfo
- Publication number
- DE69828513D1 DE69828513D1 DE69828513T DE69828513T DE69828513D1 DE 69828513 D1 DE69828513 D1 DE 69828513D1 DE 69828513 T DE69828513 T DE 69828513T DE 69828513 T DE69828513 T DE 69828513T DE 69828513 D1 DE69828513 D1 DE 69828513D1
- Authority
- DE
- Germany
- Prior art keywords
- producing nano
- nano capsules
- vesicular type
- vesicular
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
- Y10T428/2987—Addition polymer from unsaturated monomers only
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9709672 | 1997-07-24 | ||
FR9709672A FR2766368B1 (fr) | 1997-07-24 | 1997-07-24 | Procede de preparation de nanocapsules de type vesiculaire, utilisables notamment comme vecteurs colloidaux de principes actifs pharmaceutiques ou autres |
PCT/FR1998/001611 WO1999004766A1 (fr) | 1997-07-24 | 1998-07-21 | Procede de preparation de nanocapsules de type vesiculaire |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69828513D1 true DE69828513D1 (de) | 2005-02-10 |
DE69828513T2 DE69828513T2 (de) | 2006-01-05 |
Family
ID=9509787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69828513T Expired - Lifetime DE69828513T2 (de) | 1997-07-24 | 1998-07-21 | Verfahren zur herstellung von nanokapseln des vesikulären typs |
Country Status (10)
Country | Link |
---|---|
US (1) | US6884438B1 (de) |
EP (1) | EP1003488B1 (de) |
JP (1) | JP2001510790A (de) |
AT (1) | ATE286388T1 (de) |
AU (1) | AU8866198A (de) |
BR (1) | BR9815562A (de) |
CA (1) | CA2297760A1 (de) |
DE (1) | DE69828513T2 (de) |
FR (1) | FR2766368B1 (de) |
WO (1) | WO1999004766A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5877224A (en) | 1995-07-28 | 1999-03-02 | Rutgers, The State University Of New Jersey | Polymeric drug formulations |
US7838037B2 (en) | 1999-11-17 | 2010-11-23 | Tagra Biotechnologies Ltd. | Method of microencapsulation |
GB2356386A (en) * | 1999-11-17 | 2001-05-23 | Tagra Biotechnologies Ltd | Microencapsulation |
FR2806005B1 (fr) | 2000-03-10 | 2002-06-14 | Univ Claude Bernard Lyon | Procede de preparation de particules colloidales sous forme de nanocapsules |
GB0009773D0 (en) * | 2000-04-19 | 2000-06-07 | Univ Cardiff | Particulate composition |
WO2003104307A1 (en) * | 2002-06-10 | 2003-12-18 | Rhodia Inc | Phase-separated composition comprising two miscible solvents, and use thereof in a process for making capsules |
GB0216700D0 (en) * | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
GB0230088D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0230087D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0302672D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302671D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302673D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0314057D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
WO2004111033A1 (en) * | 2003-06-18 | 2004-12-23 | Astrazeneca Ab | 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
GB0314261D0 (en) * | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
FR2864900B1 (fr) * | 2004-01-09 | 2007-10-12 | Oreal | Dispersion aqueuse de nanocapsules a coeur huileux |
EP1909771A1 (de) * | 2005-08-02 | 2008-04-16 | Miv Therapeutics Inc. | Mikrovorrichtungen mit nanokapseln für die kontrollierte abgabe von arzneimitteln und herstellungsverfahren dafür |
EP1951883A2 (de) * | 2005-11-23 | 2008-08-06 | Schering Corporation | Verfahren zur quantifizierung der polymeranbindung an ein partikel |
DE102006011314A1 (de) | 2006-03-11 | 2007-10-18 | Peter Dr. Engels | Kosmetische Zubereitungen mit einem Zusatz aus der Baobab-Pflanze |
US20090074872A1 (en) * | 2006-06-26 | 2009-03-19 | Mutual Pharmaceutical Company, Inc. | Active Agent Formulations, Methods of Making, and Methods of Use |
JP5571380B2 (ja) | 2006-07-24 | 2014-08-13 | ルミナス バイオサイエンシズ,インコーポレイテッド | オストワルド熟成を減少させた水不溶性の医薬品物質の固体ナノ粒子処方物 |
FR2918888B1 (fr) * | 2007-07-18 | 2009-10-23 | Centre Nat Rech Scient | Systeme a liberation controlee d'un principe actif et procede de preparation |
FR2930176B1 (fr) | 2008-04-18 | 2011-03-18 | Univ Claude Bernard Lyon | Nouveau procede de fabrication de nanocapsules, en l'absence de solvant organique, et nanocapsules ainsi obtenues |
FR3061033A1 (fr) * | 2016-12-22 | 2018-06-29 | Centre National De La Recherche Scientifique | Procede de preparation de nanocapsules de solute et leur utilisation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2010115A1 (de) * | 1970-03-04 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Mikrogranulaten |
EP0007895B1 (de) * | 1978-07-19 | 1983-06-22 | Patrick Couvreur | Biologisch abbaubare Nanopartikeln, sie enthaltende pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung |
ATE84806T1 (de) * | 1987-04-16 | 1993-02-15 | Christian Bindschaedler | Verfahren zur herstellung eines wasserunloeslichen polymerpulvers, das in einer fluessigen phase redispergiert werden kann und verfahren zur herstellung einer dispersion des polymerpulvers. |
FR2660193B1 (fr) * | 1990-04-03 | 1994-11-04 | Philippe Maincent | Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules. |
GB9300875D0 (en) * | 1993-01-18 | 1993-03-10 | Ucb Sa | Nanocapsule containing pharmaceutical compositions |
TW493991B (en) * | 1995-05-08 | 2002-07-11 | Novartis Ag | Pharmaceutical composition for oral administration of active agent having low water solubility and process for preparation of the same |
DE19545257A1 (de) * | 1995-11-24 | 1997-06-19 | Schering Ag | Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln |
-
1997
- 1997-07-24 FR FR9709672A patent/FR2766368B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-21 DE DE69828513T patent/DE69828513T2/de not_active Expired - Lifetime
- 1998-07-21 AT AT98940304T patent/ATE286388T1/de not_active IP Right Cessation
- 1998-07-21 WO PCT/FR1998/001611 patent/WO1999004766A1/fr active IP Right Grant
- 1998-07-21 EP EP98940304A patent/EP1003488B1/de not_active Expired - Lifetime
- 1998-07-21 US US09/462,492 patent/US6884438B1/en not_active Expired - Fee Related
- 1998-07-21 CA CA002297760A patent/CA2297760A1/fr not_active Abandoned
- 1998-07-21 AU AU88661/98A patent/AU8866198A/en not_active Abandoned
- 1998-07-21 BR BR9815562-8A patent/BR9815562A/pt not_active IP Right Cessation
- 1998-07-21 JP JP2000503826A patent/JP2001510790A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2766368B1 (fr) | 2000-03-31 |
ATE286388T1 (de) | 2005-01-15 |
CA2297760A1 (fr) | 1999-02-04 |
BR9815562A (pt) | 2001-01-16 |
AU8866198A (en) | 1999-02-16 |
FR2766368A1 (fr) | 1999-01-29 |
JP2001510790A (ja) | 2001-08-07 |
WO1999004766A1 (fr) | 1999-02-04 |
EP1003488A1 (de) | 2000-05-31 |
DE69828513T2 (de) | 2006-01-05 |
US6884438B1 (en) | 2005-04-26 |
EP1003488B1 (de) | 2005-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69828513D1 (de) | Verfahren zur herstellung von nanokapseln des vesikulären typs | |
DE69727386D1 (de) | Geschmacksmaskierte flüssige suspensionen | |
ATE198150T1 (de) | Verfahren zur herstellung fester pharmazeutischer dosierungsform | |
ATA132087A (de) | Verfahren zur herstellung von neuen 2,3-dihydro-2-oxo-1h-imidazo-(4,5-b)-chinolinyl therderivaten und den pharmazeutisch vertraeglichen salzen davon | |
PT1265698E (pt) | Nanocapsulas lipidicas, processo de preparacao e utilizacao como medicamento | |
PL301841A1 (en) | Pharmaceutical agent and method of obtaining same | |
DE69828886D1 (de) | Neuartige formulierung zur inhalation mit einer bulkdichte zwischen 0.28 und 0.38 g/ml, verfahren zur herstellung der formulierung sowie anwendung derselben | |
ATE118799T1 (de) | Lösliches getrocknetes cassiagummi und verfahren zu dessen herstellung. | |
ATE61935T1 (de) | Verfahren zur herstellung von mikrokapseln. | |
ATE261337T1 (de) | Verfahren zur herstellung von morphologisch einheitlichen mikro- und nanopartikeln mittels eines mikromischers | |
ATE198152T1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
ATE97567T1 (de) | Eine suspension hydratisierter spheroide einer hydrophilen lipidsubstanz enthaltendes waessriges kosmetisches bzw. dermopharmazeutisches mittel. | |
DE60000512D1 (de) | Herstellung von Farbtinten aus wasserlöslichen Farbstoffen und speziellen Phosphoniumsalzen | |
DE60234346D1 (de) | Kosmetischer rohstoff mit verbesserten eigenschaften und verfahren zu seiner herstellung | |
DE69506122D1 (de) | Verfahren zur herstellung und verpackung von iontophoretischen pflastern und denselben, um die stabilität und die lagerstabilität zu verbessern | |
WO2001090389A3 (en) | Production of silk-like proteins in plants | |
ATE334682T1 (de) | Verfahren zur herstellung von den trans-4-n- butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)- dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung | |
ATE296791T1 (de) | Verfahren zur herstellung von direkt tablettierbarem alpha-mannit | |
PT1047355E (pt) | Processo para a producao de inlays, coroas, pontes, pontes parciais, estruturas para implantes totalmente ceramicos, ou super estruturas em odontologia | |
CA2320878A1 (fr) | Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques | |
DE3850262D1 (de) | Verfahren zur herstellung einer physiologisch aktiven substanz aus samenschalen von föhren und ein gegen infektionen aktives mittel, hauptsächlich auf der basis von diesem extrakt. | |
CA2371917A1 (en) | After shave composition containing aluminum chlorohydrate | |
ATE212041T1 (de) | Verfahren zur derivatisierung von polyglukosaminen | |
DE50009701D1 (de) | Pulverförmige Wirkstoffzusammensetzung, Verfahren zu deren Herstellung und Verwendung derselben | |
DE69515053D1 (de) | Verfahren zur herstellung von furosemide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: CBDL PATENTANWAELTE, 47051 DUISBURG |